'Inside Regulatory Affairs' With Olyos Group's Jean-Noël Perin

In this installment of HBW Insight’s “Inside Regulatory Affairs” series, Olyos Group’s quality and regulatory director, Jean-Noël Perin, explains why the regulation of food supplements requires agility, anticipation and interpretation. Perin also discusses why regulatory affairs should be seen as a powerful tool for a company's development and performance.

Inside Regulatory Affairs - Jean-Noël Perin from Olyos
• Source: Olyos

HBW Insight is shining a spotlight on the work of regulatory affairs specialists operating in and supporting the consumer health and cosmetics industries. We are profiling this important role, hearing what a typical day involves and finding out what is top of mind for these individuals today. Look out for further installments in this series in HBW Insight over the coming weeks.

More from Europe

Opella Partners With Climate Data Firm To Create Allevia-Branded ‘Pollen Passport’

 
• By 

Developed using Datair's Ambee climate data technology, Opella’s Pollen Passport presents users with an easy to use and interactive online visualization of air quality at holiday destinations across the world.

EU Ombudsman Decision A ‘Missed Opportunity’ To Bring Clarity To Probiotics Market

 
• By 

IPA Europe responds critically to recent EU Ombudsman's decision that the EC’s position in relation to probiotics is “reasonable". “While we respect the Ombudsman’s role, its conclusions fail to address the main critical concerns raised by stakeholders,” the association insists.

Alliance Pharma Set To Be Snapped Up By Private Equity

 
• By 

Offer valuing struggling UK consumer health player Alliance at £350m has the backing of the company's board of directors.

EU Probiotics Deadlock: Ombudsman Finds ‘No Maladministration’ By The Commission

 
• By 

In response to an IPA Europe complaint, European Ombudsman Emily O’Reilly finds that the Commission’s interpretation of EU food legislation in relation to probiotics is “reasonable and in line with the main goal of this legislation, which is to ensure a high level of consumer protection.”

More from Geography

Alliance Pharma Set To Be Snapped Up By Private Equity

 
• By 

Offer valuing struggling UK consumer health player Alliance at £350m has the backing of the company's board of directors.

EU Probiotics Deadlock: Ombudsman Finds ‘No Maladministration’ By The Commission

 
• By 

In response to an IPA Europe complaint, European Ombudsman Emily O’Reilly finds that the Commission’s interpretation of EU food legislation in relation to probiotics is “reasonable and in line with the main goal of this legislation, which is to ensure a high level of consumer protection.”

Haleon Completes Deal To Grow Stake In China JV

 
• By 

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.